July 9, 2020

The Niche

Knoepfler lab stem cell blog

Leigh Turner

12 min read

One of the most common questions that patients have asked me over the last decade is, “how much do stem cells cost?” They actually ask seem to want to know more specifically how much the treatments should cost. To try to authoritatively answer this we need data from the present and past along with expert perspectives. Stem cells cost & questions These kinds of questions on what are common and reasonable prices have continued in 2020. However, the types of queries have also evolved …Read More

3 min read

There is always plenty of complicated, mixed-bag news on the stem cell and regenerative medicine front so it’s great to highlight when there’s some good news out there. Today’s post includes several such upbeat items. At the bottom I’ve included a list of some recent interesting publications as well. Good news on vision front: jCyte Therapy Deal with Santen Pharmaceutical. David Jensen over at California Stem Cell Report reported on this blockbuster deal for a quarter of a billion dollars. Jensen wrote: “The California …Read More

5 min read

A Minnesota doctor running a stem cell clinic offering bone marrow injections for a variety of health conditions was subject to action by state medical regulators. The Star Tribune’s reporter Jeremy Olson has a new article on the action, which included a $13K+ fine. Pain doc gets attention of state regulators Olson’s piece has some of the key details: “Dr. Matthew Thorson was reprimanded late last year after the Minnesota Board of Medical Practice received complaints that his Stem Cell Centers of Minnesota practice …Read More

4 min read

The FDA just sent another untitled letter to a producer of a potentially non-compliant perinatal “stem cell” product that may be an unapproved drug. This follows past non-warning letters and/or inspection reports made public to Liveyon, R3 Stem Cell, Stemell, and others. RAPS has more on the story of the new letter here. This newest untitled letter went to RichSource Stem Cells, Inc. and its CEO Sara Oracle, a firm which markets an unusual “combo” product described this way by the FDA, “a combination …Read More